(Q24801115)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thrombophilia and pregnancy loss

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Intrauterine growth restriction

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thrombophilic disorders and fetal loss: a meta-analysis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Inherited thrombophilia and fetal loss

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Pregnancy loss in the antiphospholipid syndrome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Safety of low-molecular-weight heparin in pregnancy: a systematic review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thrombosis in pregnancy: maternal and fetal issues

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Etiology and pathogenesis of preeclampsia: current concepts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

The factor V Leiden mutation may predispose women to severe preeclampsia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

A study of sixty pregnancies in patients with the antiphospholipid syndrome.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Pregnancy and the risk of stroke

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Homocysteine and coronary atherosclerosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Mutation in blood coagulation factor V associated with resistance to activated protein C.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Low molecular weight heparins and their use in obstetrics and gynecology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Placental pathologic features of preterm preeclampsia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Underlying disorders associated with severe early-onset preeclampsia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

The "primary" antiphospholipid syndrome: major clinical and serological features.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Prevalence of antiphospholipid antibodies in patients with fetal loss

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Preeclampsia: an endothelial cell disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Increased frequency of genetic thrombophilia in women with complications of pregnancy.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Low-molecular-weight heparin for the treatment of venous thromboembolism

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Hyperhomocysteinemia: a risk factor for placental abruption or infarction.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Resistance to activated protein C as a basis for venous thrombosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Anti-cardiolipin antibodies and pre-eclampsia

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Antiphospholipid antibodies and recurrent abortion

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Acquired and inherited thrombophilia in women with unexplained fetal losses

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Absence of association of thrombophilia polymorphisms with intrauterine growth restriction

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Familial thrombophilia and the occurrence of fetal growth restriction

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Prothrombin G20210A Mutation: Is It Associated with Pre-Eclampsia?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Mutations in coagulation factors in women with unexplained late fetal loss.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

The effect of thrombophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V Leiden mutation.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Management of deep vein thrombosis of the lower extremity in pregnancy: a challenging dilemma.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Stroke and intracranial venous thrombosis during pregnancy and puerperium

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Increased thrombin generation in women with recurrent miscarriage.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Venous thrombosis--the interaction of genes and environment.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Increased fetal loss in women with heritable thrombophilia.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

Thromboembolic prophylaxis with low molecular weight heparin during pregnancy

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=305329

The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages

28 November 2018

1 reference

12 December 2020

Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study

1 reference

12 December 2020

Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S

1 reference

12 December 2020

Antiphospholipid antibodies and risk of intrauterine late fetal death

1 reference

12 December 2020

Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene

1 reference

12 December 2020

Technical note: compression stockings and posture: a comparative study of their effects on the proximal deep veins of the leg at rest

1 reference

12 December 2020

Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy

1 reference

12 December 2020

Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium

1 reference

12 December 2020

The challenge of thrombophilia in maternal-fetal medicine

1 reference

12 December 2020

Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages

1 reference

12 December 2020

Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies

1 reference

12 December 2020

Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia

1 reference

12 December 2020

Severe preeclampsia and high frequency of genetic thrombophilic mutations

1 reference

12 December 2020

677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia

1 reference

12 December 2020

Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome

1 reference

12 December 2020

G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population

1 reference

12 December 2020

Factor V Leiden is associated with repeated and recurrent unexplained fetal losses

1 reference

12 December 2020

Activated protein C resistance and Factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome

1 reference

12 December 2020

A mutation in the prothrombin gene contributing to venous thrombosis during pregnancy

1 reference

12 December 2020

Use of antithrombotic agents during pregnancy

1 reference

12 December 2020

Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae

1 reference

12 December 2020

Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor

1 reference

12 December 2020

Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage

1 reference

12 December 2020

Placental pathology in early onset pre-eclampsia and intra-uterine growth restriction in women with and without thrombophilia

1 reference

12 December 2020

Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia

1 reference

12 December 2020

The diagnosis of deep vein thrombosis in the puerperium

1 reference

12 December 2020

Obstetric complications associated with the lupus anticoagulant

1 reference

12 December 2020

Acute atherosis in preeclampsia: maternal determinants and fetal outcome in the presence of the lesion

1 reference

12 December 2020

Syndrome of the black swan

1 reference

12 December 2020

The association of antiphospholipid antibodies with severe preeclampsia

1 reference

12 December 2020

Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease

1 reference

12 December 2020

Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels

1 reference

12 December 2020

Severe ovarian hyperstimulation syndrome and deep venous thrombosis

1 reference

12 December 2020

Severe ovarian hyperstimulation syndrome and cerebrovascular accidents

1 reference

12 December 2020

Thromboxane dominance and prostacyclin deficiency in habitual abortion

1 reference

12 December 2020

Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study

1 reference

12 December 2020

Venous thrombosis during pregnancy: leg and trimester of presentation

1 reference

12 December 2020

Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience

1 reference

12 December 2020

A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies

1 reference

12 December 2020

Use of low molecular weight heparin in pregnancy

1 reference

12 December 2020

Antiphospholipid antibodies in pregnancy: prevalence and clinical associations

1 reference

12 December 2020

Stroke in pregnancy and the puerperium

1 reference

12 December 2020

Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria

1 reference

12 December 2020

Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia

1 reference

12 December 2020

Activated protein C resistance (FV:Q506) and pregnancy

1 reference

12 December 2020

Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss

1 reference

12 December 2020

A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure

1 reference

12 December 2020

Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort

1 reference

12 December 2020

Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5)

1 reference

12 December 2020

Thrombophilic polymorphisms are common in women with fetal loss without apparent cause

1 reference

12 December 2020

Antiphospholipid antibodies and thrombosis

1 reference

12 December 2020

Preeclampsia and genetic risk factors for thrombosis: a case-control study

1 reference

12 December 2020

Factor V leiden and factor II G20210A mutations in patients with recurrent abortion

1 reference

12 December 2020

Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy

1 reference

12 December 2020

Heparin levels to guide thromboembolism prophylaxis during pregnancy

1 reference

12 December 2020

Antiphospholipid antibodies and fetal death

1 reference

12 December 2020

Homocysteine and vascular disease

1 reference

12 December 2020

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

1 reference

12 December 2020

The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women

1 reference

12 December 2020

A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin

1 reference

12 December 2020

Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease

1 reference

12 December 2020

Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies

1 reference

12 December 2020

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies

1 reference

12 December 2020

Preeclampsia is associated with a reduced response to activated protein C

1 reference

12 December 2020

Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome

1 reference

12 December 2020

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy

1 reference

12 December 2020

Thrombophilia as a multigenic disorder

1 reference

12 December 2020

Activated protein C resistance can be associated with recurrent fetal loss

1 reference

12 December 2020

Elevated homocyst(e)ine levels with preeclampsia

1 reference

12 December 2020

Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia

1 reference

12 December 2020

A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women

1 reference

12 December 2020

The factor V Leiden mutation is not a common cause of recurrent miscarriage

1 reference

12 December 2020

Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss--a possible evolutionary selection mechanism

1 reference

12 December 2020

Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7827-1-111

1 reference

Dimensions Publication ID

2754728

1005569089

0 references

2754728

1 reference

1 reference

1 reference